but less with valsartan than with amlodipine, particularly during the first 6 months. The two groups did not differ in the primary composite endpoint of adverse cardiovascular events. However ...

The company markets products under the brand name Ahngook. Ahn-gook Pharm is headquartered in Seoul, South Korea. For a complete picture of Amlodipine + indapamide + valsartan’s drug-specific PTSR and ...

Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...

28,29 In view of the disproportionate elevation of central aortic pressures in patients with systolic hypertension and stiffened arteries, we were interested to determine whether the novel angiotensin ...

However, many of the leading drugs face patent expiration in the next 5 years, including Pfizer's Norvasc (amlodipine), which expires in late 2007. In 2006, Norvasc generated sales of $4.9 billion.